These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Clinical aspects of the treatment of obesity by drugs: a review. Munro JF Int J Obes; 1979; 3(2):171-80. PubMed ID: 393645 [TBL] [Abstract][Full Text] [Related]
26. Appetite-suppressant drugs and the risk of primary pulmonary hypertension? Deitel M Obes Surg; 1997 Feb; 7(1):3-4. PubMed ID: 9730529 [No Abstract] [Full Text] [Related]
27. Aminorex to fen/phen: an epidemic foretold. Fishman AP Circulation; 1999 Jan 5-12; 99(1):156-61. PubMed ID: 9884392 [No Abstract] [Full Text] [Related]
28. High performance liquid chromatographic determination of mazindol in human plasma. Kaddoumi A; Mori M; Nanashima K; Kono M; Nakashima K Analyst; 2001 Nov; 126(11):1963-8. PubMed ID: 11763075 [TBL] [Abstract][Full Text] [Related]
29. High incidence of primary pulmonary hypertension associated with appetite suppressants in Belgium. Delcroix M; Kurz X; Walckiers D; Demedts M; Naeije R Eur Respir J; 1998 Aug; 12(2):271-6. PubMed ID: 9727773 [TBL] [Abstract][Full Text] [Related]
30. Temporal trends and drug exposures in pulmonary hypertension: an American experience. Walker AM; Langleben D; Korelitz JJ; Rich S; Rubin LJ; Strom BL; Gonin R; Keast S; Badesch D; Barst RJ; Bourge RC; Channick R; Frost A; Gaine S; McGoon M; McLaughlin V; Murali S; Oudiz RJ; Robbins IM; Tapson V; Abenhaim L; Constantine G Am Heart J; 2006 Sep; 152(3):521-6. PubMed ID: 16923424 [TBL] [Abstract][Full Text] [Related]
31. [Anorectics and pulmonary hypertension]. Bíbová J; Hampl V Cas Lek Cesk; 2000 Feb; 139(3):67-70. PubMed ID: 10838744 [TBL] [Abstract][Full Text] [Related]
33. [Drug-induced primary vascular pulmonary hypertension. Contribution to its etiology and clinical course]. Schnabel KH; Schulz V; Busch S; Just H Med Welt; 1976 Jun; 27(26):1300-3. PubMed ID: 933821 [No Abstract] [Full Text] [Related]
34. Proceedings: The epidemic of primary pulmonary hypertension in Europe. Lüthy E Pathol Microbiol (Basel); 1975; 43(2-O):246-7. PubMed ID: 1228586 [No Abstract] [Full Text] [Related]
35. Two different drug-induced pulmonary complications in a patient suffering from rheumatoid arthritis. Leeb BF; Scheinecker C; Schweitzer H; Smolen JS Br J Rheumatol; 1998 May; 37(5):586-7. PubMed ID: 9651097 [No Abstract] [Full Text] [Related]
36. A century of pulmonary hemodynamics. Fishman AP Am J Respir Crit Care Med; 2004 Jul; 170(2):109-13. PubMed ID: 15242851 [No Abstract] [Full Text] [Related]
37. Anorexigen-induced pulmonary hypertension and the serotonin (5-HT) hypothesis: lessons for the future in pathogenesis. Eddahibi S; Adnot S Respir Res; 2002; 3(1):9. PubMed ID: 11806844 [TBL] [Abstract][Full Text] [Related]
38. Semen-like urethral discharge during the use of mazindol. van Puijenbroek EP; Meyboom RH Int J Eat Disord; 1998 Jul; 24(1):111-3. PubMed ID: 9589318 [TBL] [Abstract][Full Text] [Related]
39. Appetite suppressants and primary pulmonary hypertension in the United Kingdom. Thomas SH; Butt AY; Corris PA; Egan JJ; Higenbottam TW; Madden BP; Waller PC Br Heart J; 1995 Dec; 74(6):660-3. PubMed ID: 8541174 [TBL] [Abstract][Full Text] [Related]
40. Mazindol administration improved hyperphagia after surgery for craniopharyngioma--case report. Sadatomo T; Sakoda K; Yamanaka M; Kutsuna M; Kurisu K Neurol Med Chir (Tokyo); 2001 Apr; 41(4):210-2. PubMed ID: 11381681 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]